Suppr超能文献

替硝唑和非甾体抗炎药对类风湿关节炎中培养的人T细胞对白介素-2反应的影响。

Effects of tenidap and nonsteroidal antiinflammatory drugs on the response of cultured human T cells to interleukin 2 in rheumatoid arthritis.

作者信息

Hall V C, Wolf R E

机构信息

Center of Excellence for Arthritis and Rheumatology, Louisiana State University Medical Center, Shreveport 71130, USA.

出版信息

J Rheumatol. 1997 Aug;24(8):1467-70.

PMID:9263136
Abstract

OBJECTIVE

To assess the effects of tenidap, a new oxindole class antiinflammatory compound, on the proliferative response of cultured T cells to interleukin 2 (IL-2); and to compare these effects with the antiinflammatory drugs ibuprofen, naproxen, indomethacin, piroxicam, and sulindac.

METHODS

T cells were cultured with either tenidap, ibuprofen, indomethacin, naproxen, piroxicam, or sulindac in the presence of IL-2, then assayed for incorporation of tritiated thymidine.

RESULTS

Tenidap, ibuprofen, and naproxen, at therapeutically attainable concentrations, significantly inhibited the proliferative response of T cells to IL-2. In contrast, indomethacin, piroxicam, and sulindac did not alter this response. Tenidap had a direct inhibitory effect on the response of activated T cells to IL-2. Both ibuprofen and naproxen interfered with the binding of IL-2 to T cells.

CONCLUSION

These results suggest variable effects of different antiinflammatory drugs on lymphocyte function that may relate to the differential effectiveness of these drugs in patients with rheumatoid arthritis.

摘要

目的

评估新型异吲哚类抗炎化合物替硝唑对培养的T细胞对白介素2(IL-2)增殖反应的影响;并将这些影响与抗炎药物布洛芬、萘普生、吲哚美辛、吡罗昔康和舒林酸进行比较。

方法

将T细胞与替硝唑、布洛芬、吲哚美辛、萘普生、吡罗昔康或舒林酸在IL-2存在的情况下进行培养,然后检测氚标记胸腺嘧啶核苷的掺入情况。

结果

在可达到治疗浓度的情况下,替硝唑、布洛芬和萘普生显著抑制T细胞对IL-2的增殖反应。相比之下,吲哚美辛、吡罗昔康和舒林酸未改变这种反应。替硝唑对活化T细胞对IL-2的反应有直接抑制作用。布洛芬和萘普生均干扰IL-2与T细胞的结合。

结论

这些结果表明不同抗炎药物对淋巴细胞功能的影响各异,这可能与这些药物在类风湿关节炎患者中的不同疗效有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验